HPTN Publications

Juraska M, Bai H, deCamp AC, Magaret CA, Li L, Gillespie K, Carpp LN, Giorgi EE, Ludwig J, Molitor C, Hudson A, Williamson BD, Espy N, Simpkins B, Rudnicki E, Shao D, Rossenkhan R, Edlefsen PT, Westfall DH, Deng W, Chen L, Zhao H, Bhattacharya T, Pankow A . Prevention efficacy of the broadly neutralizing antibody VRC01 depends on HIV-1 envelope sequence features. Proc Natl Acad Sci U S A. 2024, 121: e2308942121

Justman J, Befus M, Hughes J, Wang J, Golin CE, Adimora AA, Kuo I, Haley DF, Del Rio C, El-Sadr WM, Rompalo A, Mannheimer S, Soto-Torres L, Hodder S . Sexual Behaviors of US Women at Risk of HIV Acquisition: A Longitudinal Analysis of Findings from HPTN 064. AIDS Behavior. 2015, 19: 1327-37

Justman J, Goldberg A, Reed J, Bock N, Njeuhmeli E, Goldzier Thomas A . Adult male circumcision: reflections on successes and challenges. J Acquir Immune Defic Syndr. 2013, 63: S140-3

Justman J, Skalland T, Moore A, Amos CI, Marzinke MA, Zangeneh SZ, et al. . Prevalence of SARS-CoV-2 Infection among Children and Adults in 15 US Communities. Emerg Infect Dis. 2024, 30: 245-254

K Buchacz, J Farrior, G Beauchamp, L McKinstry, AE Kurth, BS Zingman, FM Gordin, D Donnell, KH Mayer, WM El-Sadr, B Branson . Changing Clinician Practices and Attitudes Regarding the Use of Antiretroviral Therapy for HIV Treatment and Prevention. J Int Assoc Physicians AIDS Care. 2017, 16: 81-90

K. Rivet Amico, Melissa Wallace, Linda-Gail Bekker, Surita Roux, Millicent Atujuna, Elaine Sebastian, Bonnie J. Dye, Vanessa Elharrar, Robert M. Grant, Amico KR, Wallace M, Bekker LG, Roux S, Atujuna M, Sebastian E, Dye BJ, Elharrar V, Grant RM . Experiences with HPTN 067/ADAPT Study-Provided Open-Label PrEP Among Women in Cape Town: Facilitators and Barriers Within a Mutuality Framework. AIDS and Behavior. 2017, 21: 1361-1375

Kaleebu P, Njai HF, Wang L, Jones N, Ssewanyana I, Richardson P, Kintu K, Emel L, Musoke P, Fowler MG, Ou SS, Jackson JB, Guay L, Andrew P, Baglyos L, Cao H; HPTN 027 protocol team . Immunogenicity of ALVAC-HIV vCP1521 in Infants of
HIV-1–Infected Women in Uganda (HPTN 027): The First
Pediatric HIV Vaccine Trial in Africa. J Acquir Immune Defic Syndr. 2014, 65: 268-77

Kalichman SC, Zohren L, Eaton LA . Setting the bar high or setting up to fail? Interpretations and implications of the EXPLORE Study (HPTN 015). AIDS Behav. 2014, 18: 625-33